Fixed left ventricular outflow tract obstruction mimicking hypertrophic obstructive cardiomyopathy: pitfalls in

Chadi Ayoub1,2, David Brieger2,3, Richard Chard3,4

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Insights

Diagnosing left ventricular outflow tract obstruction (LVOTO) and left ventricular hypertrophy (LVH) can be challenging. Distinguishing fixed LVOTO from hypertrophic obstructive cardiomyopathy (HOCM) is crucial for appropriate patient management and treatment.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Diagnostics

Background:

  • Left ventricular hypertrophy (LVH) and left ventricular outflow tract obstruction (LVOTO) present diagnostic challenges.
  • Fixed structural lesions in the left ventricular outflow tract (LVOT) can mimic hypertrophic obstructive cardiomyopathy (HOCM).
  • The management strategies for LVOTO and HOCM differ significantly.

Observation:

  • This case series highlights the difficulties in differentiating fixed LVOTO with secondary LVH from HOCM.
  • Clinical examination, Doppler echocardiography, and advanced imaging are essential for accurate diagnosis.
  • Failure to correctly identify the level and type of LVOT obstruction can lead to adverse outcomes.

Findings:

  • Accurate differentiation between fixed LVOTO and HOCM is critical.
  • Misdiagnosis can result in inappropriate therapies and delayed surgical intervention.
  • Comprehensive evaluation is necessary to identify the specific cause and location of LVOT obstruction.

Implications:

  • Correctly diagnosing LVOTO and LVH is vital for effective patient treatment.
  • Timely and accurate diagnosis prevents patient morbidity associated with incorrect management.
  • Advanced imaging and clinical correlation are key to optimizing care for patients with LVOT obstruction.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
413
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
724
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
838